Drug Safety and Pharmacovigilance (PV) Software Market - Global Outlook and Forecast 2021-2027

Drug Safety and Pharmacovigilance (PV) Software Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687450 | No. of Pages: 91 | Category: Services
Publisher: Market Monitor Global | Date of Publish: Apr-2021
This report contains market size and forecasts of Drug Safety and Pharmacovigilance (PV) Software in Global, including the following market information:
Global Drug Safety and Pharmacovigilance (PV) Software Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Drug Safety and Pharmacovigilance (PV) Software market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Safety and Pharmacovigilance (PV) Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Safety and Pharmacovigilance (PV) Software Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Drug Safety and Pharmacovigilance (PV) Software Market Segment Percentages, By Type, 2020 (%)
On-Premises
Cloud-Based

China Drug Safety and Pharmacovigilance (PV) Software Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Drug Safety and Pharmacovigilance (PV) Software Market Segment Percentages, By Application, 2020 (%)
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other

Global Drug Safety and Pharmacovigilance (PV) Software Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Drug Safety and Pharmacovigilance (PV) Software Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Drug Safety and Pharmacovigilance (PV) Software Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Drug Safety and Pharmacovigilance (PV) Software Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
ArisGlobal (US)
Ennov Solutions Inc. (US)
EXTEDO GmbH (US)
Online Business Applications, Inc. (US)
Oracle Corporation (US)
Sarjen Systems Pvt. Ltd (India)
Sparta Systems, Inc. (US)
United BioSource Corporation (US)
1 Introduction to Research & Analysis Reports
    1.1 Drug Safety and Pharmacovigilance (PV) Software Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Drug Safety and Pharmacovigilance (PV) Software Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Drug Safety and Pharmacovigilance (PV) Software Overall Market Size
    2.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size: 2021 VS 2027
    2.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Drug Safety and Pharmacovigilance (PV) Software Players in Global Market
    3.2 Top Global Drug Safety and Pharmacovigilance (PV) Software Companies Ranked by Revenue
    3.3 Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Companies
    3.4 Top 3 and Top 5 Drug Safety and Pharmacovigilance (PV) Software Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Drug Safety and Pharmacovigilance (PV) Software Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Drug Safety and Pharmacovigilance (PV) Software Players in Global Market
        3.6.1 List of Global Tier 1 Drug Safety and Pharmacovigilance (PV) Software Companies
        3.6.2 List of Global Tier 2 and Tier 3 Drug Safety and Pharmacovigilance (PV) Software Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Drug Safety and Pharmacovigilance (PV) Software Market Size Markets, 2021 & 2027
        4.1.2 On-Premises
        4.1.3 Cloud-Based
    4.2 By Type - Global Drug Safety and Pharmacovigilance (PV) Software Revenue & Forecasts
        4.2.1 By Type - Global Drug Safety and Pharmacovigilance (PV) Software Revenue, 2016-2021
        4.2.2 By Type - Global Drug Safety and Pharmacovigilance (PV) Software Revenue, 2022-2027
        4.2.3 By Type - Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Drug Safety and Pharmacovigilance (PV) Software Market Size, 2021 & 2027
        5.1.2 Pharma and Biotech Companies
        5.1.3 Contract Research Organizations (CROs)
        5.1.4 Business Process Outsourcing (BPO) Firms
        5.1.5 Other
    5.2 By Application - Global Drug Safety and Pharmacovigilance (PV) Software Revenue & Forecasts
        5.2.1 By Application - Global Drug Safety and Pharmacovigilance (PV) Software Revenue, 2016-2021
        5.2.2 By Application - Global Drug Safety and Pharmacovigilance (PV) Software Revenue, 2022-2027
        5.2.3 By Application - Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Drug Safety and Pharmacovigilance (PV) Software Market Size, 2021 & 2027
    6.2 By Region - Global Drug Safety and Pharmacovigilance (PV) Software Revenue & Forecasts
        6.2.1 By Region - Global Drug Safety and Pharmacovigilance (PV) Software Revenue, 2016-2021
        6.2.2 By Region - Global Drug Safety and Pharmacovigilance (PV) Software Revenue, 2022-2027
        6.2.3 By Region - Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Drug Safety and Pharmacovigilance (PV) Software Revenue, 2016-2027
        6.3.2 US Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.3.3 Canada Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.3.4 Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Drug Safety and Pharmacovigilance (PV) Software Revenue, 2016-2027
        6.4.2 Germany Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.4.3 France Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.4.4 U.K. Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.4.5 Italy Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.4.6 Russia Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.4.7 Nordic Countries Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.4.8 Benelux Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Drug Safety and Pharmacovigilance (PV) Software Revenue, 2016-2027
        6.5.2 China Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.5.3 Japan Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.5.4 South Korea Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.5.5 Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.5.6 India Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Drug Safety and Pharmacovigilance (PV) Software Revenue, 2016-2027
        6.6.2 Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.6.3 Argentina Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Revenue, 2016-2027
        6.7.2 Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.7.3 Israel Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.7.4 Saudi Arabia Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
        6.7.5 UAE Drug Safety and Pharmacovigilance (PV) Software Market Size, 2016-2027
7 Players Profiles
    7.1 ArisGlobal (US)
        7.1.1 ArisGlobal (US) Corporate Summary
        7.1.2 ArisGlobal (US) Business Overview
        7.1.3 ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Major Product Offerings
        7.1.4 ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Revenue in Global (2016-2021)
        7.1.5 ArisGlobal (US) Key News
    7.2 Ennov Solutions Inc. (US)
        7.2.1 Ennov Solutions Inc. (US) Corporate Summary
        7.2.2 Ennov Solutions Inc. (US) Business Overview
        7.2.3 Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Major Product Offerings
        7.2.4 Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue in Global (2016-2021)
        7.2.5 Ennov Solutions Inc. (US) Key News
    7.3 EXTEDO GmbH (US)
        7.3.1 EXTEDO GmbH (US) Corporate Summary
        7.3.2 EXTEDO GmbH (US) Business Overview
        7.3.3 EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Major Product Offerings
        7.3.4 EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Revenue in Global (2016-2021)
        7.3.5 EXTEDO GmbH (US) Key News
    7.4 Online Business Applications, Inc. (US)
        7.4.1 Online Business Applications, Inc. (US) Corporate Summary
        7.4.2 Online Business Applications, Inc. (US) Business Overview
        7.4.3 Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Major Product Offerings
        7.4.4 Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue in Global (2016-2021)
        7.4.5 Online Business Applications, Inc. (US) Key News
    7.5 Oracle Corporation (US)
        7.5.1 Oracle Corporation (US) Corporate Summary
        7.5.2 Oracle Corporation (US) Business Overview
        7.5.3 Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Major Product Offerings
        7.5.4 Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Revenue in Global (2016-2021)
        7.5.5 Oracle Corporation (US) Key News
    7.6 Sarjen Systems Pvt. Ltd (India)
        7.6.1 Sarjen Systems Pvt. Ltd (India) Corporate Summary
        7.6.2 Sarjen Systems Pvt. Ltd (India) Business Overview
        7.6.3 Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Major Product Offerings
        7.6.4 Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Revenue in Global (2016-2021)
        7.6.5 Sarjen Systems Pvt. Ltd (India) Key News
    7.7 Sparta Systems, Inc. (US)
        7.7.1 Sparta Systems, Inc. (US) Corporate Summary
        7.7.2 Sparta Systems, Inc. (US) Business Overview
        7.7.3 Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Major Product Offerings
        7.4.4 Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue in Global (2016-2021)
        7.7.5 Sparta Systems, Inc. (US) Key News
    7.8 United BioSource Corporation (US)
        7.8.1 United BioSource Corporation (US) Corporate Summary
        7.8.2 United BioSource Corporation (US) Business Overview
        7.8.3 United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Major Product Offerings
        7.8.4 United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Revenue in Global (2016-2021)
        7.8.5 United BioSource Corporation (US) Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com